









Markets
/
Stocks
/
nasdaq-kmts
/

Kestra Medical Technologies Ltd

KMTS

27.520USD

-0.030-0.11%

Close 12/24, 13:00（ET）Quotes delayed by 15 min

1.42BMarket Cap

LossP/E TTM



Kestra Medical Technologies Ltd

27.520

-0.030-0.11%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Kestra Medical Technologies Ltd to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

---18.34M

---26.27M

---23.70M

---18.38M

Net income from continuing operations

---32.78M

---25.83M

---51.11M

---21.76M

Operating gains losses

--2.37M

--2.03M

--1.84M

--1.89M

Deferred tax

----

--64.00K

----

Other non-cash items

--1.58M

--1.55M

--3.15M

--258.00K

Change in working capital

--711.00K

---5.98M

---3.46M

--123.00K

-Change in receivables

---1.71M

---1.78M

---2.85M

---2.54M

-Change in prepaid expenses

--813.00K

--140.00K

---1.69M

---335.00K

-Change in other current assets

---126.00K

---450.00K

---756.00K

---1.64M

Cash from non-recurring investing activities

Cash from operating activities

---18.34M

---26.27M

---23.70M

---18.38M

Investing cash flow

Net cash from continuing investing activities

--7.26M

--8.17M

--7.39M

--4.06M

Capital expenditures

--7.26M

--8.17M

--7.39M

--4.06M

Net cash flow from disposal of fixed assets

--7.26M

--8.17M

--7.39M

--4.06M

Net cash flow from investment products

---155.00K

---66.00K

---372.00K

----

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

---7.42M

---8.23M

---7.76M

---4.06M

Financing cash flow

Cash flow from continuous financing activities

---27.00K

---1.88M

--214.70M

---119.00K

Net cash flow from debt Issuance/repayment

----

--0.00

Net cash flow from common stock issuance/repurchase

----

--218.16M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

Net cash flow from other financing activities

----

---1.88M

---3.46M

---119.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

---27.00K

---1.88M

--214.70M

---119.00K

Net cash flow

Beginning cash balance

--201.55M

--237.93M

--54.69M

--77.25M

Current period cash flow changes

---25.79M

---36.38M

--183.24M

---22.57M

Effect of exchange rate changes

--175.42M

----

Ending cash balance

--175.76M

--201.55M

--237.93M

--54.69M

Free cash flow

---25.61M

---34.44M

---31.09M

---22.45M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

